Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Schools have been a point of attention during the pandemic, and their closure one of the mitigating measures taken. A better understanding of the dynamics of the transmission of SARS-CoV-2 in elementary education is essential to advise decisionmakers. We conducted an uncontrolled non-interventional prospective study in Belgian French-speaking schools to describe the role of attending asymptomatic children and school staff in the spread of COVID-19 and to estimate the transmission to others. Each participant from selected schools was tested for SARS-CoV-2 using a polymerase chain reaction (PCR) analysis on saliva sample, on a weekly basis, during six consecutive visits. In accordance with recommendations in force at the time, symptomatic individuals were excluded from school, but per the study protocol, being that participants were blinded to PCR results, asymptomatic participants were maintained at school. Among 11 selected schools, 932 pupils and 242 school staff were included between January and May 2021. Overall, 6449 saliva samples were collected, of which 44 came back positive. Most positive samples came from isolated cases. We observed that asymptomatic positive children remaining at school did not lead to increasing numbers of cases or clusters. However, we conducted our study during a period of low prevalence in Belgium. It would be interesting to conduct the same analysis during a high prevalence period.

Details

Title
SARS-CoV-2 Transmission in Belgian French-Speaking Primary Schools: An Epidemiological Pilot Study
Author
Frère, Julie 1 ; Chatzis, Olga 2 ; Cremer, Kelly 3   VIAFID ORCID Logo  ; Merckx, Joanna 4   VIAFID ORCID Logo  ; De Keukeleire, Mathilde 3   VIAFID ORCID Logo  ; Renard, Florence 5 ; Ribesse, Nathalie 5 ; Minner, Frédéric 6   VIAFID ORCID Logo  ; Ruelle, Jean 7 ; Kabamba, Benoit 8   VIAFID ORCID Logo  ; Rodriguez-Villalobos, Hector 9 ; Bearzatto, Bertrand 10   VIAFID ORCID Logo  ; Marie-Luce Delforge 11 ; Henin, Coralie 12   VIAFID ORCID Logo  ; Bureau, Fabrice 6 ; Gillet, Laurent 6 ; Annie, Robert 3 ; Van der Linden, Dimitri 2 

 Pediatric Infectious Diseases, Pediatric Department, CHU Liège, 4000 Liège, Belgium 
 Pediatric Infectious Diseases, Specialized Pediatric Service, Pediatric Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium 
 Department of Epidemiology and Biostatistics, Institut de Recherche Expérimentale et Clinique, Faculty of Public Health, UCLouvain, 1200 Brussels, Belgium 
 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC H3A 1A2, Canada 
 Office de la Naissance et de l’Enfance (ONE), 1060 Brussels, Belgium 
 Immunology-Vaccinology Lab of the Faculty of Veterinary Medicine, ULiège, 4000 Liège, Belgium 
 Pôle de Microbiologie Médicale (MBLG), UCLouvain, 1200 Brussels, Belgium; SmartGene Services, EPFL Innovation Park, 1015 Lausanne, Switzerland 
 Department of Epidemiology and Biostatistics, Institut de Recherche Expérimentale et Clinique, Faculty of Public Health, UCLouvain, 1200 Brussels, Belgium; Pôle de Microbiologie Médicale (MBLG), UCLouvain, 1200 Brussels, Belgium 
 Department of Epidemiology and Biostatistics, Institut de Recherche Expérimentale et Clinique, Faculty of Public Health, UCLouvain, 1200 Brussels, Belgium; Department of Microbiology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium 
10  Institut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), UCLouvain, 1200 Brussels, Belgium 
11  Institut de Biologie Clinique de l’Université Libre de Bruxelles, 1070 Brussels, Belgium 
12  Federal Testing Platform for COVID-19, Université Libre de Bruxelles, 1070 Brussels, Belgium 
First page
2199
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
19994915
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2728551070
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.